{
    "id": "dbpedia_8203_0",
    "rank": 43,
    "data": {
        "url": "https://www.biopharma-reporter.com/tag/keyword/Pharma/Ajinomoto%2520Bio-Pharma",
        "read_more_link": "",
        "language": "en",
        "title": "Ajinomoto bio",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.biopharma-reporter.com/content/download/3061/9283809?version=12",
            "https://www.biopharma-reporter.com/content/download/3061/18689?version=12",
            "https://www.biopharma-reporter.com/content/download/3061/4362127?version=12",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2023/01/10/adc-deals-ajinomoto-and-exelixis-team-up-french-biotech-secures-funding-for-payload-program/16067963-1-eng-GB/ADC-deals-Ajinomoto-and-Exelixis-team-up-French-biotech-secures-funding-for-payload-program.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2021/11/03/from-the-show-floor-cphi-worldwide-2021/12979997-2-eng-GB/From-the-show-floor-CPhI-Worldwide-2021.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/pharmaceutical-science/outsourcing-pharma.com/headlines/drug-delivery/free-webinar-innovations-in-drug-delivery-part-ii/11570154-1-eng-GB/Free-webinar-Innovations-in-Drug-Delivery-Part-II.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/ajinomoto-to-supply-covid-19-treatment-for-cytodyn/10973930-1-eng-GB/Ajinomoto-to-supply-COVID-19-treatment-for-CytoDyn.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/genedesign-joins-ajinomoto-bio-pharma/9393903-1-eng-GB/GeneDesign-joins-Ajinomoto-Bio-Pharma.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/ajinomoto-announces-further-expansion/9297184-1-eng-GB/Ajinomoto-announces-further-expansion.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/outsourcing-pharma.com/trends/patient-centricity/women-in-science-ann-graham-from-fighting-cancer-to-helping-kids/17627269-1-eng-GB/Women-in-Science-Ann-Graham-from-fighting-cancer-to-helping-kids.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/07/30/women-in-science-deep-genomics-tehmina-masud/17612998-1-eng-GB/Women-in-Science-Deep-Genomics-Tehmina-Masud.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/07/23/inspiring-women-in-science-laura-child-s-journey/17604322-1-eng-GB/Inspiring-women-in-science-Laura-Child-s-journey.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/07/15/women-in-science-jasmina-jankicevic-her-life-in-science/17585455-1-eng-GB/Women-in-Science-Jasmina-Jankicevic-her-life-in-science.png",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/07/11/antibody-developer-cytodyn-settles-clash-with-cro-for-12m/17577394-1-eng-GB/Antibody-developer-CytoDyn-settles-clash-with-CRO-for-12M.jpg",
            "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/hot-topics/antibody-drug-conjugates/scirhom-funding-to-be-used-for-antibody-drug-known-as-sr-878/17576449-1-eng-GB/SciRhom-funding-to-be-used-for-antibody-drug-known-as-SR-878.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "biopharma-.com"
        ],
        "publish_date": "2008-02-14T00:00:00",
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/bundles/wrbmgbsite/images/favicon/biopharma_reporter/favicon.ico",
        "meta_site_name": "biopharma-reporter.com",
        "canonical_link": "https://www.biopharma-reporter.com/tag/keyword/Pharma/Ajinomoto Bio-Pharma",
        "text": "ADC deals: Ajinomoto and Exelixis team up, French biotech secures funding for payload program\n\nThere has been a flurry of antibody-drug conjugate (ADC) agreements in recent weeks, and today sees the inking of another deal involving Tokyo headquartered Ajinomoto Co Inc and US biotech, Exelixis.\n\nFrom the show floor: Exhibitors at CPhI Worldwide 2021\n\nCPhI Worldwide welcomes attendees back to the show floor in person this month. We put the spotlight on some of the exhibitors who will be there.\n\nWebinar delves into drug delivery innovations\n\nInnovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.\n\nAjinomoto to produce potential COVID-19 treatment for CytoDyn\n\nAjinomoto agrees partnership to manufacture leronlimab, which is currently undergoing clinical trials for the treatment of COVID-19."
    }
}